TABLE 2.
Marker | Cell population (% ± SD)a
|
|||||
---|---|---|---|---|---|---|
BLV−
|
AL
|
PL
|
||||
Ex vivob | Culturedc | Ex vivo | Cultured | Ex vivo | Cultured | |
CD2 | 38 ± 8 | 72 ± 13 | 57 ± 11 | 72 ± 7 | 18 ± 1 | 48 ± 10 |
CD4 | 17 ± 4 | 19 ± 1 | 37 ± 8 | 38 ± 5 | 13 ± 4 | 24 ± 7 |
CD8 | 13 ± 7 | 47 ± 5 | 16 ± 4 | 11 ± 2de | 7 ± 2 | 27 ± 8f |
Surface IgM | 30 ± 3 | NDg | 36 ± 5 | 15 ± 4 | 56 ± 8 | 28 ± 11 |
γδ-TcR | 14 ± 2 | 21 ± 14 | 15 ± 3 | 41 ± 3de | 9 ± 4 | 8 ± 2h |
For ex vivo cells, n = 10 for all groups. For cultured cells: BLV−, n = 3 (of 8); AL, n = 10 (of 10); PL, n = 10 (of 10).
Ex vivo cells are nonexpanded PBM cells freshly isolated from blood.
Nonadherent cells were cultured with endogenously expressed BLV antigen for 2 to 3 days and then rhIL-2 (50 U/ml) for an additional 7 to 9 days.
Statistically different from BLV− (P < 0.001).
Statistically different from PL (P < 0.001).
Statistically different from BLV− (P < 0.005).
ND, not determined.
Not statistically different from BLV− (P > 0.025).